Armata Pharmaceuticals, Inc. (ARMP)
5.60
+0.08
(+1.45%)
USD |
NYAM |
Sep 04, 12:24
Armata Pharmaceuticals 1 Year Total Returns (Daily) : 84.00% for Sept. 3, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 03, 2026 | 84.00% |
| September 02, 2026 | 116.9% |
| September 01, 2026 | 111.2% |
| August 31, 2026 | 120.4% |
| August 28, 2026 | 109.8% |
| August 27, 2026 | 122.5% |
| August 26, 2026 | 110.0% |
| August 25, 2026 | 113.9% |
| August 24, 2026 | 92.91% |
| August 21, 2026 | 109.9% |
| August 20, 2026 | 76.10% |
| August 19, 2026 | 99.61% |
| August 18, 2026 | 74.71% |
| August 17, 2026 | 75.69% |
| August 14, 2026 | 80.24% |
| August 13, 2026 | 92.80% |
| August 12, 2026 | 75.20% |
| August 11, 2026 | 80.08% |
| August 10, 2026 | 90.90% |
| August 07, 2026 | 99.58% |
| August 06, 2026 | 81.82% |
| August 05, 2026 | 82.88% |
| August 04, 2026 | 72.69% |
| August 03, 2026 | 98.82% |
| July 31, 2026 | 85.31% |
| Date | Value |
|---|---|
| July 30, 2026 | 99.18% |
| July 29, 2026 | 88.07% |
| July 28, 2026 | 98.74% |
| July 27, 2026 | 115.5% |
| July 24, 2026 | 87.53% |
| July 23, 2026 | 117.5% |
| July 22, 2026 | 123.0% |
| July 21, 2026 | 116.8% |
| July 20, 2026 | 110.8% |
| July 17, 2026 | 86.36% |
| July 16, 2026 | 59.32% |
| July 15, 2026 | 62.20% |
| July 14, 2026 | 71.18% |
| July 13, 2026 | 78.83% |
| July 10, 2026 | 87.67% |
| July 09, 2026 | 117.6% |
| July 08, 2026 | 135.0% |
| July 07, 2026 | 160.3% |
| July 06, 2026 | 150.7% |
| July 02, 2026 | 203.6% |
| July 01, 2026 | 211.1% |
| June 30, 2026 | 241.1% |
| June 29, 2026 | 223.0% |
| June 26, 2026 | 287.4% |
| June 25, 2026 | 226.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Agenus, Inc. | 93.43% |
| Amgen, Inc. | 60.78% |
| Anika Therapeutics, Inc. | 133.1% |
| BioCryst Pharmaceuticals, Inc. | 21.71% |
| Imunon, Inc. | -72.77% |